Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Erytech and MD Anderson to Develop Companion Dx for L-Asparaginase Drug in Solid Tumors
February 17, 2010
The aim of the collaboration "is to have a companion test for Graspa and to stratify [patients] according to the level of asparagine synthetase in their tumor cells," Erytech Pharma CEO Yann Godfrin said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- Erytech Pharma, MD Anderson Ink Companion Dx Deal
February 15, 2010 / GenomeWeb Daily News - MD Anderson Evaluating Transgenomic's Ice-Cold PCR for CTC Analysis
March 20, 2012 / GenomeWeb Daily News - Sequencing Study Suggests Potential New Treatments for ALL Subset with Poor Response
January 25, 2012 / Pharmacogenomics Reporter - Sequenta Looks to 2013 for Launch of Sequencing-based Cancer Test
January 23, 2012 / GenomeWeb Daily News - SLCO1B1 Sequencing Study Suggests PGx Genotyping May Not ID Enough Rare Variants
December 14, 2011 / Pharmacogenomics Reporter